Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - AMERICAN GENE ENGINEER CORP | Financial_Report.xls |
| 10-Q - FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2015 - AMERICAN GENE ENGINEER CORP | j6515110q.htm |
| EX-31.2 - EXHIBIT 31.2 - AMERICAN GENE ENGINEER CORP | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - AMERICAN GENE ENGINEER CORP | ex31_1.htm |
| EX-32.2 - EXHIBIT 32.2 - AMERICAN GENE ENGINEER CORP | ex32_2.htm |
Exhibit 32.1
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of American Gene Engineer Corp. (the "Company") on Form 10-Q for the quarter ended April 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ming Lin, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Ming Lin
|
|
Ming Lin
Principal Executive Officer
|